News & Articles

A single reader minimizes space requirements, training burden, and maintenance contracts for endotoxin detection

Lonza now offers human cord blood CD34+ hematopoietic stem cells in large batch sizes, leading the way in addressing a critical unmet market need

The agreement will provide prevalidated hepatocytes for use on innovative organ-on-a-chip range

The addition of the PyroWave XM Fluorescent Reader complements the existing absorbance readers used in traditional LAL-based assays

The new lots further enhance Lonza’s renowned human primary cell offerings as it looks to meet growing market demand for deeper cell characterization

Lonza has collaborated with CELLINK to offer a comprehensive 3-dimensional (3D) bioprinting solution designed to advance complete 3D cell culture workflows

The new medium promises to boost and optimize the production of AAV in Sf9 insect cells

The eCHO™ Medium is ideal for the manufacture of recombinant proteins for medical use, including monoclonal antibodies and complex glycoproteins

Lonza and AllCells team up to offer an extensive range of hematopoietic primary cells to reach the global scientific community

First glimpse of next-generation solution for endotoxin detection at PDA 2018

Fermentation strategy results in drastically-reduced fermentation times and high product titers up to 6 g/L